 |
| |
|
|
Options VI Conference Highlights
Due to the overwhelming success of the Options VI conference, we are pleased to announce Options VI Conference Highlights, the Live-meeting alternative.
Registration Overview
Registration for 1-year unlimited access to Conference Highlights is $150 USD. A valid e-mail account and credit card are required to register.
For more information visit controlinfluenza.com
Options VI Conference Registration is Closed
We are no longer taking registrations and on-site registration will not be available.
To Submit a Manuscript Click Here
June 17-23, 2007
Metro Toronto Convention Centre
255 Front Street West
Toronto, Ontario, Canada |
| |
Options for the Control of Influenza has grown from
a small scientific symposium in 1985 to what is today
the largest international conference exclusively devoted
to influenza, and covering every imaginable topic from
basic science to healthcare policy. Whatever your
domain of expertise—science, veterinary medicine,
human medicine, public health policy, industry, or the
media—your insight is needed to meet the challenges
of a single threat: Influenza.
Knowledge is power: your participation in Options VI
will provide up-to-the-minute access to comprehensive
information and key authorities spanning the full extent
of influenza research, prevention, control, and treatment.
Nancy J Cox, PhD – Chair
Director, Influenza Division
Director, WHO Collaborating Center for
Epidemiology and Control of Influenza
National Center for Immunizations and
Respiratory Diseases (proposed)
Coordinating Center for Infectious Disease
Centers for Disease Control and Prevention
Atlanta, Georgia, USA
|
| |
 |
Download the Welcome Letter |
| |
|
|
The key objectives of Options VI include:
Provide comprehensive, state-of-the-art scientific information for all disciplines involved in influenza prevention, control, and treatment, including seasonal and pandemic planning
Promote genuine international and multidisciplinary collaboration supporting the full spectrum of influenza research, from basic science, to the development of new vaccines and antiviral agents, to epidemiology and control programs
Provide a collegial atmosphere within which scientists working in public health and scientists working in agricultural or veterinary agencies may exchange information to develop collaborative approaches to the control and prevention of pandemic influenza
Maximize the opportunities for informal discussions and exchange of ideas between representatives of government agencies, academia, and industry |
|
|
|
